Research Insights Weight Loss and Obesity Management Clinical studies show that individuals treated with GLP-1 (S) experienced weight reductions of up to 15% over 68 weeks, significantly outperforming placebo groups ( 2, 3 )
Fluorescence emissions at 665 nm and 620 nm following excitation at 320 nm were detected using an Envision reader (Perkin Elmer) and data were transformed to % Delta F as described in manufacturers guidelines
Cover or dab with cotton wool if necessary If you are struggling to follow the above or have questions, please do get in touch with our nurses COPYRIGHT NOTICE This B12 page is 2020- Ivy Grove Surgery and may not be reproduced without permission
Planning ahead can reduce this risk
So, it doesnt appear to be a direct effect of the drug
It works as a GLP-1 receptor agonist, mimicking a naturally occurring hormone that regulates appetite and blood sugar to reduce hunger, slow gastric emptying, and support sustained weight loss over time